🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$MCRB

Seres Therapeutics Inc

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 05, 2026 ☀️ Open🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP0.24%
MAX GAP RECORD13.19%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.9%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL